• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Pharmacology introduction
Pharmacology introduction

...  Essential medicines, as defined by the WHO are "those drugs that satisfy the health care needs of the majority of the population; they should therefore be available at all times in adequate amounts and in appropriate dosage forms, at a price the community can afford." ...
With each succeeding year, more drugs are released, every one
With each succeeding year, more drugs are released, every one

... With each succeeding year, more drugs are released, every one with the hope and the promise that it is an improvement over its *predecessor. Although the pharmaceutical industry must be given most of the **credit for advances in drug therapy, it is also true that many new drugs have only a marginal ...
Developing Consumer Marketing Claims within the Clinical
Developing Consumer Marketing Claims within the Clinical

... toxic to the liver than the other two drugs” [HHS News, 3/21/00] “And we’ve had to withdraw drugs from the market that would have been safe if used according to label instructions” [Janet Woodcock, Temple University, 4/4/00] Not to mention the “pain” in the pain reliever market ...
Treatments for Alzheimer`s Disease
Treatments for Alzheimer`s Disease

... Alzheimer’s disease. The drugs are expensive, generally costing more than $100 a month. The most common side effects are stomach upset and diarrhea. These do not affect everyone who takes these drugs. In order to avoid this type of side effect, the medication is started at a low dose and gradually i ...
History of psychopharmacology
History of psychopharmacology

... American psychiatry, psychotherapeutic drugs became a foundation of psychiatric treatment (Kaplan & Sadock, 1998). Over the following decade the prescription of antidepressant, antianxiety and antipsychotic drugs became common practice among psychiatrists. The next 30 years were dedicated to clinica ...
Tina said you all learned ALOT last week
Tina said you all learned ALOT last week

... How does this make you feel about the clinical studies that have been done with little attention to race/ethnicity? ...
1 Background The Federal Food, Drug and Cosmetic Act
1 Background The Federal Food, Drug and Cosmetic Act

... The ability of drug candidates to induce cancer has historically been evaluated in two-year rodent bioassays, where mice and rats are dosed with compounds for their lifetime and the number and type of tumors are enumerated. This bioassay takes up to three years to complete and costs $2 to $3 million ...
Basic Pharmacology
Basic Pharmacology

... • OTC drugs: drugs that may be purchased without a prescription • Pharmacodynamics: what drugs do to the body and how drugs interact with body tissue • Prescription drugs: require a prescription to be dispensed • Side effect: an additional effect of a drug that isn't the necessary purpose of the med ...
Substance abuse
Substance abuse

... • May be pharmacokinetic or pharmacodynamic tolerance • pharmacokinetic : induction of hepatic metabolic enzymes e.g. barbiturates; • pharmacodynamic: alteration at receptor levels e.g. decrease of GABA receptors followed by increase of barbiturate administration; morphine and its receptor. • Tolera ...
B.P.T. [2 Prof.] Pharmacology
B.P.T. [2 Prof.] Pharmacology

... Diabetic patients who are taking Insulin should avoid Alcohol drink. In variant Angina beta - blockers are avoided. On and off phenomenon occurs after chronic use of Levodopa in Parkinson's disease. Female on oral contraceptives should not be given rifampicin. ...
Chapter 9, Section 1
Chapter 9, Section 1

... Lifetime Health Chapter 9, Section 1 Drugs ...
The Medicalizing of America
The Medicalizing of America

... normal serum cholesterol, obesity, hypertension and diabetes? By placing untold millions of people on potent drugs and exposing large numbers of the population to years of worry, let alone unnecessary medication with its cost and complications, could we be doing more harm than good? Do New Cutoff Po ...
86a-CO-Pharmacology
86a-CO-Pharmacology

... Learning Objectives - Give them info on Pharmacology so they can more knowledgably evaluate indications and contraindications in their practice. Make them generally aware of the subject and guide them through the handout in the packet so they can access it with familiarity in the future. ...
BP 404 T. PHARMACOLOGY-I (Theory)
BP 404 T. PHARMACOLOGY-I (Theory)

... how their effects can be applied to therapeutics. The subject covers the information about the drugs like, mechanism of action, physiological and biochemical effects (pharmacodynamics) as well as absorption, distribution, metabolism and excretion (pharmacokinetics) along with the adverse effects, cl ...
SECZYL TABLET
SECZYL TABLET

...  Has a longer terminal elimination half-life (approximately 17 to 29 hours) than commonly used drugs in this class. Secnidazole have a much longer half-life than Metronidazole, allowing single-dose or once daily administration. DOSAGE One day treatment: Secnidazole is given 2 gm as a single dose af ...
Write down on your post it note
Write down on your post it note

... drugs can have on the body To consider the reasons why people start using drugs ...
“Development of IPF drugs: a slow process fraught with failures” Not
“Development of IPF drugs: a slow process fraught with failures” Not

... Not long ago, doctors had no proven treatment options for their IPF patients. Today, Canadian IPF patients can be treated with Esbriet (pirfenidone), and encouraging clinical data suggests a second option, nintenamib, may soon be available. Part of the reason why novel drugs are so slow to become av ...
Write down on your post it note - PE-Teaching
Write down on your post it note - PE-Teaching

... drugs can have on the body To consider the reasons why people start using drugs ...
A1987L059000002
A1987L059000002

... locally acted as a vasoconstrictor but systemically lowered the blood pressure. It took the medical profession some time to realize that a “sympathomimetic” may serve as an antihypertensive drug. A review article is a favourite for a Citation Classic if the editor selects the suitable author at the ...
Drugs that may Cause or Worsen Symptoms of Myasthenia Gravis
Drugs that may Cause or Worsen Symptoms of Myasthenia Gravis

... Associated with more common or more severe adverse events Associated with less common or less severe adverse events *Indicates agents with documented effects in MG, other drugs belonging to the same drug classes (benzodiazepines, beta-blockers, muscle relaxants) may have similar effects and should b ...
document
document

... which makes the person feel better, not high. when they are taken repeatedly or in large doses. They can alter the reward system, making it harder to feel good without the drug and can lead to intense cravings, which make it hard to stop using. This is no different from what can happen when someone ...
February 2007 Toxtidbits
February 2007 Toxtidbits

... controlled substances). Cases presenting to EMS providers and emergency departments with adulterated drugs are problematic in that signs and symptoms don’t correlate with the history. In many cases, toxscreens won’t confirm the presence or absence of the drugs involved. The Maryland Poison Center (M ...
understanding drugs and medicinces what is the
understanding drugs and medicinces what is the

... Drugs are substances that cause a change in a person’s physical and/or psychological state. ...
An Efficient Reward System for Pharmaceutical Innovation
An Efficient Reward System for Pharmaceutical Innovation

... • Another perspective is that if we want to encourage firms to invest in research in therapies for rare diseases, we need to allow them to earn massive excess profits far above those that would more than compensate them for the risks of their investment and the relevant cost of ...
- Celon Pharma S.A.
- Celon Pharma S.A.

... Salmex ready to conquer the USA Celon Pharma concluded an agreement on cooperation with Lupin Atlantis Ltd., an international pharmaceutical company with its registered seat in Switzerland, with regard to obtaining marketing authorisation, distribution and sale of Salmex, a drug used in treatment of ...
< 1 ... 156 157 158 159 160 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report